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Abstract: Single glycan–protein interactions are often weak,
such that glycan binding partners commonly utilize multiple,
spatially defined binding sites to enhance binding avidity
and specificity. Current array technologies usually neglect
defined multivalent display. Laser-based array synthesis tech-
nology allows for flexible and rapid on-surface synthesis of
different peptides. By combining this technique with click
chemistry, neo-glycopeptides were produced directly on a
functionalized glass slide in the microarray format. Density
and spatial distribution of carbohydrates can be tuned, re-
sulting in well-defined glycan structures for multivalent dis-
play. The two lectins concanavalin A and langerin were
probed with different glycans on multivalent scaffolds, re-
vealing strong spacing-, density-, and ligand-dependent
binding. In addition, we could also measure the surface dis-
sociation constant. This approach allows for a rapid genera-
tion, screening, and optimization of a multitude of multiva-
lent scaffolds for glycan binding.
Introduction
Glycan arrays are indispensable tools to screen carbohydrate
interaction partners in high-throughput. They offer many dif-
ferent glycans, immobilized as spots on a solid surface. Since
the advent of glycan microarrays some 20 years ago,[1] they
have become a standard tool[2] in the discovery of novel inter-
actions. Applying this technology, various binding studies were
already successfully carried out over the last years.[3] Since
many pathogens infect a host by binding to cell-surface gly-
cans using glycan binding proteins (GBPs), called lectins, the
screening of such interactions represents a cornerstone in the
field.[4]
Intrinsic (per binding site) glycan–protein affinities are weak
(KDmm–mm)[2a] and GBPs can often interact with diverse sub-
strates, due to their rather low specificity. To improve weak
binding and low specificity, binding domains of pathogens are
often equipped with multiple, spatially defined glycan binding
sites to enhance avidity.[5] This effect is known as multivalency
and serves as a common strategy in nature to achieve high
avidity between glycans and GBPs.
Still, multivalent effects are somewhat difficult to screen and
not yet fully understood.[6] Therefore, multivalency, one of the
key aspects in glycan recognition processes, is often neglected,
since glycan density and spacing on a standard solid support
is difficult to control.[7] Flexible and rapid methods for precise
spatial distribution and orientation of glycans on a microarray
need to be developed to screen GBPs for the identification of
strong, selective, and reliable binders.[8]
To mimic the natural occurrence of glycans, many different
multivalent scaffolds have been pre-synthesized in different
shapes.[9] Peptide chemistry has been widely employed to
attach sugars at specific positions onto chemically well-defined
backbones, leading to multivalent glycoconjugates with con-
trolled spatial arrangement.[10] A major challenge is the transfer
of such methods to the preparation of spatially defined glycan
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microarrays. Usually, arrays are printed on solid supports, ignor-
ing the specific glycan spacing and density within each spot.
As a result, glycans are attached to the surface in an uncontrol-
led way, which can result in reproducibility problems and the
loss of glycan binding events due to mismatched spacing.[11]
Additionally, an excess in glycan density can lead to suppres-
sion of the binding due to steric hindrance. Thus, only spatially
defined glycan microarrays can solve this problem.
The simplest way to tune glycan density on the microarray
is the direct printing of glycan containing solutions of various
concentrations or by modifying the surface functionalization
density.[11a, 12] This method provides good qualitative results re-
garding multivalency of GBPs, although the organization of
the glycans remains random. Another, yet more defined ap-
proach for multivalent display of glycans on microarrays, is the
printing of pre-synthesized or natural multivalent scaffolds.
Those molecules already provide a defined multivalency of the
glycan moieties. Through the printing process, the density can
be regulated according to the applied concentration of the
spotting solution. In this way, glycoconjugates, such as natural
glycoproteins,[13] neo-glycoproteins/neo-glycopeptides,[1, 14] gly-
codendrimers,[15] glycan-conjugated DNA,[16] glycoclusters,[17]
and glycopolymers[18] were used to fabricate microarrays, dis-
playing multivalent carbohydrate structures. These approaches
usually require labor-intensive multistep pre-syntheses for each
compound. In addition, subsequent array printing can suffer
from fluctuating compound solubility and density, immobiliza-
tion efficiency, as well as sometimes poor spot morphology.
Hence, a promising strategy to generate defined multivalen-
cy in the microarray format is the on-chip synthesis, which
means the step-wise synthesis directly on the final microarray
surface. This should allow for a more rapid and reproducible
production of such arrays. Since glycan synthesis is quite chal-
lenging, only disaccharides have been successfully synthesized
directly on a surface using purely chemical approaches.[19] Al-
ternatively, other approaches have been investigated to gener-
ate multivalent glycan structures on-chip. A remarkable exam-
ple is the use of photopolymerization to grow brush-like glyco-
polymers with distinct multivalency on a solid support by vary-
ing the irradiation time.[20] Another method to create multiva-
lency is the pre-immobilization of scaffolds that bear a distinct
number of functional groups for glycan attachments.[11b]
Here, we present a flexible alternative, using our new combi-
natorial laser-induced forward transfer (cLIFT) technology.[21] In
combination with copper(I)-catalyzed alkyne–azide cycloaddi-
tion (CuAAC), we synthesized neo-glycopeptides directly on a
functionalized glass slide to manufacture microarrays. Since
our approach does not require cumbersome pre-synthesis of
individual scaffolds, it offers a rapid and flexible method for
multivalent glycan structures synthesis, with a defined spot
morphology and a controlled immobilization efficiency.
Results and Discussion
We applied the cLIFT technology, which is used for on-chip
peptide synthesis (see Experimental Section).[21] In brief, differ-
ent donor slides are produced (Figure 1 A), containing different
amino acid building blocks. These building blocks are laser-
transferred to an acceptor, where the on-chip chemical synthe-
sis is performed (Figure 1 B). We synthesized arrays of different
synthetic peptide sequences, containing various numbers of
the alkyne-functionalized amino acid l-propargylglycine (Pra).
Subsequently, we used CuAAC to attach azido-functionalized
sugars to these distinct positions on the peptide backbone.
Then, we studied the interactions of the fluorescently labeled
lectins concanavalin A (ConA) and human langerin by fluores-
cence scanning. In addition, by varying the lectin concentra-
tion, we could determine the (surface) dissociation constant
KD,surf of ConA regarding different neo-glycopeptide sequences.
On-chip peptide synthesis using the cLIFT technology
We used the two amino acid derivatives Fmoc-Pra-OPfp 1 and
Fmoc-Gly-OPfp 2 to synthesize all sixteen variants of the possi-
ble peptide tetramers in a microarray format. The commercially
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Figure 1. cLIFT process. (A) Preparation of activated amino acid (AA) donor
slides by spin coating. (B) Transfer of activated amino acid and polymer
matrix using cLIFT. For details see Experimental Section; rps = rounds per
second.
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available 3D Fmoc-NH-b-Ala-PEGMA-co-MMA glass slides were
used as acceptor slides for the peptide synthesis. Prior to the
synthesis, the surface was functionalized with a PEG-based
spacer (for details, see Experimental Section and Supporting In-
formation), followed by the cLIFT synthesis of two glycines.
This increases the distance of the to-be-synthesized molecules
from the solid support to make them more accessible for sub-
sequent GBP interaction studies. After attachment of the
spacers and Fmoc deprotection, the free amino groups were
used as the starting point for peptide synthesis. Two donor
slides, one containing Fmoc-Pra-OPfp 1 (B) and the other
Fmoc-Gly-OPfp 2 (G), were employed to synthesize the sixteen
tetrapeptide combinations of the two amino acids (synthesis
on solid support starts from the C-terminus, Figure 2, naming
convention from N- to C-terminus, for example, N-GGGB-C).
For each amino acid layer, the laser transfer and the coupling
reaction were performed three times to increase the synthesis
yield and reduce potential deletion sequences. The coupling
reaction, which forms the amide bond between the transferred
amino acid and the solid support, was conducted in an oven
under inert gas atmosphere at 90 8C. At this temperature, the
glass-transition temperature of the inert polymer matrix is ex-
ceeded, which enables diffusion and coupling of the amino
acids within the polymer matrix spots. To ensure that each
amino acid layer is repetitively transferred on top of the previ-
ous one, the acceptor slide was aligned on a positioning table
by three mechanical springs and a vacuum fixation. This forces
the acceptor slide always into the same position (Figure 6 and
Supporting Information). The peptides were synthesized as
three sets of quadruplicates on one array (the resulting bind-
ing intensity is the mean of 12 spots).
To assess the array synthesis quality, we first clicked in a car-
boxytetramethylrhodamine (TAMRA) azide fluorescent dye and
analyzed the fluorescence intensity. For peptides containing
one Pra (i.e. , one dye molecule per scaffold), we observe
highly similar staining intensities. This shows that the synthesis
yield is comparable. Interestingly, for all other sequences with
more than one Pra, we observe less intensity than in the latter
case. This can be attributed to the FRET mechanism,[22] causing
self-quenching of multiple adjacent dye molecules (see
Figure 3). For more information, see Supporting Information.
On-chip CuAAC for neo-glycopeptide formation
The copper(I)-catalyzed alkyne-azide cycloaddition (CuAAC) has
previously been exploited to fabricate glycopolymers[10c,e, 23] or
to install glycans or glycoconjugates on a solid support.[18a,d, 24]
Here, we used the CuAAC to attach a small collection of azide-
functionalized saccharides onto the peptide tetramers
(Figure 2) to form neo-glycopeptides. The sugar azides 3–10
Figure 2. Overview of the synthesized peptide tetramers. (A) Illustration of the acceptor slide with the tetrapeptide spot pattern created through cLIFT. Six-
teen different tetrapeptides (1I-1VIII and 2I-2VIII) were synthesized from C- to N-terminus using the two amino acids Fmoc-Pra-OPfp 1 (= B) and Fmoc-Gly-
OPfp 2 (= G) ; naming convention from N-to C-terminus: N-XXXX-C-(array surface), X = B/G. Each dashed square represents one sequence as quadruplicate
spots. (B) Structures of the peptides according to the position of the squares.
Figure 3. General reaction conditions for neo-glycopeptide formation using
CuAAC and theoretical spacing estimates in a simplified scaffold (for more
information, see Supporting Information).
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and 21 were synthesized from the unmodified monomer build-
ing blocks (see Figure 4 and supporting information).[25] For
each of the sugar azides, the CuAAC was performed on an in-
dividual array, using standard CuAAC conditions (Figure 3). We
also approximated the theoretical spacing in a scaffold (see
Supporting Information). Each array contains the peptide tetra-
mer pattern shown in Figure 2 as three replicas, yielding a
total of twelve neo-glycopeptide replicas for each combination
of sugar azide and peptide tetramer (three sets of quadrupli-
cates).
Lectin binding assays, fluorescence scanning, and analysis
We generated neo-glycopeptide arrays that result from the
CuAAC between the mannose azides 3–6, glucose azides 7
and 8, galactose azide 21, and the peptide tetramer pattern
shown in Figure 2. The arrays were incubated with fluorescent-
ly labeled concanavalin A (ConA), 100 mg mL1 in HEPES-buffer
containing manganese and calcium ions. The galactose azide
21, as well as the plain peptides without any click modification
served as negative controls (see Supporting Information).
The neo-glycopeptides bearing the glucosamine (b-GlcNTs)
azide 9 and the human blood group B trisaccharide azide 10
respectively, were incubated with fluorescently labeled langer-
in, 63 mg mL1 in HEPES-buffer, containing calcium ions. As a
negative control, we used glucose azide 7, as well as the plain
peptides without any click modification (see Supporting Infor-
mation).
A fluorescence scan was performed and the staining intensi-
ty was analyzed. In Figure 4 (A and B: ConA; C: langerin), for
each microarray with the respective sugar azide, the fluores-
cence staining intensity is presented after lectin incubation.
The bar charts show the mean values of the in total twelve
spots (three sets of quadruplicate spots) for each neo-glyco-
peptide (see Supporting Information).
General trends
We observed a strong spacing-, density-, and ligand-depen-
dent binding. Comparing the binding of the four monovalent
scaffolds (GGGB, GGBG, GBGG, BGGG) with only one Pra (i.e. ,
sugar) unit, we observe very similar binding for each com-
pound/lectin combination. Thus, these ligands seem to offer
similar binding strength, which confirms our initial results with
the dye-azide.
Furthermore, different ligands show large differences in
binding strength and their spatial distance within the neo-gly-
copeptide has a significant impact.
Concanavalin binders
According to literature, ConA should only bind to a-Man 6 and
a-Glc 7, not to b-Glc 8. For the following analysis of our results
(Figure 4 A), we considered the binding signal of the poly-gly-
cine peptide GGGG as the background signal. Monovalent scaf-
folds of a-Man bind about twofold stronger than a-Glc. No sig-
Figure 4. Fluorescence staining intensities of the respective sugar-azide microarrays. (A, B) ConA (CF633 labeled) staining was performed at a concentration
of 100 mg mL1 on different arrays with different sugar azides (3–8 are shown). Weaker (A) and stronger (B) binding ligands for ConA are shown in separate
graphs. (C) Human langerin (FITC labeled) staining was performed at a concentration of 63 mg mL1 on different arrays with different sugar azides (9, 10 are
shown). The results show significant spacing-, density-, and ligand-dependent binding effects. For more information, see Supporting Information.
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nificant binding to b-Glc could be detected. However, ConA
binding to a-Man increases exponentially with linear increase
in the number of sugars on the scaffold, which clearly indicates
multivalent interaction: In comparison to monovalent a-Man
structures, divalent a-Man scaffolds show a 7- to 17-fold signal
increase, trivalent scaffolds an 18- to 30-fold, and the tetrava-
lent a 37-fold increase.
Comparing a-Glc and a-Man scaffolds, binding to divalent
a-Man >5-fold higher than that to divalent a-Glc. Tri- and tet-
ravalent a-Man scaffolds show a 7- to 10-fold higher signal
over the respective a-Glc scaffolds.
In contrast to monovalent a-Glc scaffolds, the binding to di-,
tri-, and tetravalent a-Glc scaffolds only increases 2- to 11-fold.
Especially for some divalent scaffolds with two directly adja-
cent Pra in the sequence (GGBB, GBBG, BBGG, theoretical spac-
ing 2.1 nm), we observed an only two-fold signal increase
over the monovalent structures, indicating non-multivalent in-
teraction. Binding to multivalent b-Glc scaffolds is generally
very weak.
Furthermore, spacing plays an important role (see support-
ing information): Interestingly, scaffolds with two directly adja-
cent Pra in the sequence (GGBB, GBBG, BBGG, theoretical spac-
ing 2.1 nm) show generally less binding, whereas non-adja-
cent divalent structures (GBGB, BGGB, BGBG, theoretical spac-
ing 0.7 nm and 2.3 nm) show stronger binding. Similarly,
for trivalent binders, an intermittent glycine (BGBB, BBGB) in-
creases the binding, in comparison to terminal glycines (GBBB,
BBBG).
In addition, the orientation of the sugar-azides on the scaf-
fold also have an effect. According to our simple spacing
model, the scaffolds GBGB and BGBG should theoretically
show the same results due to similar spacing. Yet, the latter
shows less binding, which may be caused by the opposite ori-
entation of the sugars on the scaffold.
Next, introducing a C5 alkyl spacer between the azide and
the anomeric position of a glycan significantly increases bind-
ing (a-Man-C5 3 vs. a-Man 6 ; Figure 4 A vs. B). This alkyl spacer
should increase the flexibility of the sugars on the scaffold,
which makes it more accessible to the lectins. For monovalent
a-Man-C5, we observe a 70-fold increase in binding in compari-
son to monovalent a-Man ligands, a 30-fold for divalent, a
15-fold for trivalent, and a 10-fold increase for tetravalent
ligands.
In comparison to monomannose 3, a-1,6-linked di-manno-
side 5 is a similarly good binder. Yet, only for the tetravalent
scaffold, a-1,6-linked di-mannoside is an even better binder. As
already seen with a-Man 6, we observe for both compounds 3
and 5 a very similar spacing effect on binding.
Finally, a-1,2-linked di-mannoside 4 is our strongest ob-
served binder for ConA. Only one dimer unit suffices to result
in saturated binding at this ConA concentration. Due to satura-
tion, further increase in valency has no effect.
Langerin binders
The tosylated glucosamine (b-GlcNTs) 9 was found to be a se-
lective and strong binder for langerin,[25c] while blood group B
trisaccharide 10 is known for a weak affinity to langerin.[26] We
can confirm these results and see very similar effects of spac-
ing and multivalent glycan display on the langerin binding as
for the two ConA binders a-Man 6 and a-Glc 7.
KD,surf determination
To assess the surface dissociation constant of ConA to our scaf-
folds, we generated eight microarrays, all containing the neo-
glycopeptides based on mannose azide 3. We incubated them
with a dilution series (45–5760 nm) of fluorescently labeled
ConA in a HEPES-buffer containing manganese and calcium
ions, to determine the KD,surf values for each of the sixteen neo-
glycopeptides. The result of the fluorescence scan is shown in
Figure 5. The fluorescence intensity for all ConA concentrations
Figure 5. Fluorescence intensities (arbitrary units) of the neo-glycopeptides (containing mannose azide 3) on the microarray (compare Figure 2) after incuba-
tion with CF633 ConA at various concentrations. The strongest binding is achieved with the peptide, offering the highest number of mannoses. Fluores-
cence images can be found in the supporting information.
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is plotted against the respective peptide sequences. The
curves follow the same binding trends as described above for
monomannose 3 in Figure 4 for all the applied ConA concen-
trations. Using the data shown in Figure 5, we determined the
surface dissociation constant KD,surf for the different neo-glyco-
peptides (Table 1) by using a nonlinear curve fitting approach.
With increasing number of mannose units on the peptide, the
binding strength of ConA increases, leading to smaller KD,surf
values due to multivalency effects. The synthesized neo-glyco-
peptides reach dissociation constants in the low micromolar
range between 1 mm 4 mm. In the literature, different disso-
ciation constants KD,surf have been reported. They are highly de-
pendent on the usually not well-defined multivalent interac-
tion and range from the micromolar to the low nanomolar
range.[27] Often, it is reported to be about 200 nm, whereas
we observed a five times lower value. We believe that this is
mainly due to the protein resistance of the PEGMA-co-MMA
functionalized glass slides for our microarray synthesis, which
are known to be protein resistant.[28] Only by introducing a
poly(ethylene glycol)3-spacer on these surfaces prior to the
peptide scaffold synthesis, we could observe sufficient binding
of ConA. Spacers and surface functionalization are known to
sometimes have significant effects on lectin binding.[29]
Conclusions
We have developed a flexible and facile approach to synthe-
size glycan microarrays for multivalent display. By synthesizing
different peptides directly on-chip as scaffolds in the microar-
ray format, we can attach different azido-sugars or other azido-
functionalized molecules. This protocol circumvents the cum-
bersome pre-synthesis of individual multivalent scaffolds in
multistep syntheses.
With these glycan microarrays, we observed that the binding
of the lectins to different ligands is dependent on spacing and
density. ConA binds strongly to a-mannose compounds 3–6,
with the strongest binding to a-1,2-linked di-mannose 4. With
our standard concentration, the binding to 4 already plateaued
for monovalent scaffolds, whereas additional ligands on a scaf-
fold did not increase its binding strength. Human langerin
binds strongly to the b-GlcNTs azide 9, strongly depending on
the number of ligands. Moreover, it also binds to the human
blood group B trisaccharide azide 10, but in a much less spac-
ing- and valency-dependent manner.
One current limitation of this approach is the synthesis sur-
face: Since we used PEGMA-co-MMA functionalized glass slides
for our arrays, which are known to be protein resistant,[28] we
had to introduce a PEG-spacer on the surface. Only then, we
could observe significant binding of ConA. In a recent study,
lectin interactions regarding different glycan array surface coat-
ings, linkers/spacers, and densities were compared.[29] A strong
impact of a-Man density on ConA binding was observed, while
many other lectin–glycan interactions did not show this de-
pendency.
Besides the glass surface coating, also the molecular orienta-
tion on the scaffold has an impact on the multivalent display:
The theoretical spacing between the two scaffolds BGBG and
GBGB should be similar, yet, the binding strength differs, likely
due to opposite orientation on the scaffold. In the future, we
want to investigate this with molecular dynamics simulations.
Furthermore, we also want to test different commercially avail-
able surfaces, which can offer better properties for probing
weakly interacting binders. In addition, larger and longer scaf-
folds should increase the binding even further.
To our knowledge, this is the first time that multivalent
glycan scaffolds with molecularly defined valency, length, and
spacing have been synthesized directly on-chip. Since the tech-
nology is also available as a low-budget system, it can be em-
ployed by almost every laboratory in the world.[21b] In the
future, our laser-based synthesis approach will be automated
with a robot.[30] This will allow for an easy incorporation of ad-
ditional building blocks to synthesize diverse peptide-based
scaffolds to generate diverse arrays of glycopeptides. We be-
lieve that the results are valuable for the design and prepara-
tion of multivalent carbohydrate microarrays and their applica-
tion for functional studies of glycan binding proteins and
pathogen binding. We expect that with this approach, we can
generate a multitude of different multivalent neo-glycopepti-
des, combining natural and synthetic amino acids with differ-
ent glycan structures.
Experimental Section
Preparation of the donor and acceptor slides
Donor slide preparation : Microscope glass slides (Marienfeld Superi-
or, Lauda-Kçnigshofen/Baden-Wrttemberg, Germany; size 76 
26  1 mm, ground edges, pure white glass) were covered on one
Table 1. Determined KD,surf values for the neo-glycopeptides shown in
Figure 5.[a]
Entry Neo-glycopeptide Number of a-mannose 3 KD,surf [mm]
1 GGGG 0 NB[b]
2 GGGB 1 3.440.56[c]
3 GGBG 1 3.560.50[c]
4 GBGG 1 3.930.74[c]
5 BGGG 1 3.840.52[c]
6 GGBB 2 1.150.08
7 GBGB 2 1.110.10
8 BGGB 2 1.210.13
9 BGBG 2 1.410.12
10 BBGG 2 1.480.18
11 GBBG 2 1.400.13
12 BBBG 3 1.160.07
13 BBGB 3 1.080.09
14 BGBB 3 0.930.42[d]
15 GBBB 3 1.040.07
16 BBBB 4 0.990.07
[a] For the fitting curves see supporting information. [b] Since no sugar
unit is present on this peptide, no binding of ConA can occur. NB = no
binding. [c] Hypothetical fit values, since saturation was not reached (see
supporting information). [d] A different fit model had to be used (stan-
dard model did not converge), causing a larger standard deviation.
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side with self-adhesive polyimide foil (Kapton, DuPont, USA; CMC
Klebetechnik GmbH, Frankenthal/Rheinland-Pfalz, Germany; thick-
ness of polyimide layer approx. 25 mm, thickness of glue layer
approx. 45 mm). The transfer material was spin coated at 80 rps on
top of the polyimide foil, using a spin coater device (Schaefer Tech-
nologie GmbH, Langen/Hessen, Germany; KLM Spin-Coater SCC-
200). Different spin coating solutions were prepared. Therefore,
3.00 mg of the l-amino acid building block pentafluorophenyl
(OPfp)-activated Fmoc-Gly-OPfp 2 and 27.0 mg of inert polymer
matrix (SLEC PLT 7552, Sekisui Chemical GmbH, Dsseldorf/Nordr-
hein-Westfalen, Germany) were dissolved in a mixture of 450 mL
DCM and 50 mL DMF. In case of the non-activated Fmoc-Pra-OH, a
solution containing 2.17 mg of l-amino acid, 27.0 mg of inert poly-
mer matrix, 1.00 mL DIC, and 1.19 mg PfpOH in a mixture of 450 mL
DCM and 50 mL DMF was applied, which forms the desired Fmoc-
Pra-OPfp 1 in situ (see Supporting Information).
Acceptor slides : The 3D Fmoc-NH-b-Ala-PEGMA-co-MMA glass slides
(25 nm thick coating, loading of functional groups 1 nmol cm2, es-
timated functional group spacing of 7–10 nm) were acquired from
PEPperPRINT GmbH (Heidelberg/Baden-Wrttemberg, Germany).
For the on-chip synthesis of the peptide tetramers, the slides were
initially modified with a PEG-based spacer as shown in the sup-
porting information, to improve the accessibility of the surface
bound molecules for the lectins.
cLIFT machine setup
We use a laser system, consisting of a 200 mW TOPTICA iBeam
smart 488-S laser with a wavelength of 488 nm (TOPTICA Photonics
AG, Grfelfing/Bayern, Germany), which is passed through a 1:10
beam expander and a Racoon 11 laser scanning system (ARGES
GmbH, Wackersdorf/Bayern, Germany), equipped with an f-Theta-
lens (S4LFT5110/322, Sill Optics GmbH, Wendelstein/Bayern, Ger-
many). This setup facilitates to scan the focus of the laser beam in
a 66 mm  66 mm plane, which enables reproducible irradiation of
a surface at various positions for a high-quality cLIFT process
(Figure 6). The slide holder table (lasing area) is equipped with
three mechanical springs and a vacuum mechanism to ensure the
same alignment of the acceptor slide when placing it in the
holder.
cLIFT technique parameters
For the arrays with a pitch of 250 mm, we used 60 % laser power
and a pulse duration of 6 ms per spot. The resulting spot diameter
is about 150 mm.
General cLIFT process
The cLIFT process is conducted in the lasing area as seen in
Figure 6. Therefore, the acceptor slide is placed on the slide holder
with the functionalized side facing upwards. The donor slide is
placed on top of the acceptor slide with the spin coated side
facing down. When the donor slide is irradiated with the laser
beam, the light passes through the microscope glass slide and hits
the polyimide foil. The polyimide foil expands, hits the acceptor
slide and, thereby, transfers small amounts of the inert polymer
matrix[32] with the activated amino acid as a tiny spot onto the ac-
ceptor slide.
General on-chip synthesis of peptides using cLIFT
After initial preparation of the donor and acceptor surfaces, our
current protocol for the synthesis of 4-mer peptide (scaffold) arrays
comprises 12 synthesis steps. One step for each peptide chain
elongation (four), which we repeated three times to increase the
coupling yield. Including more building blocks is simple and does
not require significantly more time.
Peptide array synthesis : The commercially available 3D Fmoc-NH-
b-Ala-PEGMA-co-MMA glass slide (PEPperPRINT GmbH, Heidelberg/
Baden-Wrttemberg, Germany) was used as the acceptor slide for
the peptide synthesis. Before starting the actual synthesis of the
peptides, the whole slide was first functionalized with a PEG ((EG)3)
-based spacer (17  length, see supporting information), leading
to free amino groups on the surface. Without this spacer, lectin
binding is too weak for detection. The first layer of OPfp-activated
and Fmoc-protected amino acids was transferred via cLIFT using
two different donor slides to create a combinatorial pattern on the
acceptor slide. The coupling reaction was accomplished by heating
the slide in an oven under inert gas atmosphere at 90 8C for 1 h.
Subsequently, the slide was washed with acetone (2  2 min in a
petri dish on a shaker) and dried in a jet of air. The cLIFT transfer
of the same amino acid pattern, the coupling step, and the wash-
ing procedure were repeated twice. Free remaining amino groups
on the slide were capped (acetylated) by immersing the slide in
10 mL of capping solution (20 % DIPEA and 10 % acetic anhydride
in DMF), first for 2 min in an ultrasonic bath and then for 30 min
on a shaker. The capping solution was replaced by a freshly pre-
pared one and shaking was continued for an additional 30 min.
The slide was washed consecutively with DMF (3  5 min), MeOH
(1  2 min), DCM (1  1 min), and dried in a jet of air. Terminal
Fmoc-groups were removed by immersing the slide in 10 mL of
Fmoc-deprotection solution (20 % piperidine in DMF) for 20 min on
a shaker. The slide was washed consecutively with DMF (3  5 min),
MeOH (1  2 min), DCM (1  1 min), and dried in a jet of air. For sub-
sequent layers of amino acids, the whole process was repeated for
each pattern to synthesize the desired peptides.
Figure 6. Lasing machine setup (cLIFT) showing the different components.
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In case of the last amino acid within the peptide chain, the Fmoc-
removal was accomplished before the capping step to have an
acetyl group at the N-terminus instead of a bulky Fmoc-protecting
group.
Synthesis of the sugar azides
The human blood group B trisaccharide 10 was obtained by enzy-
matic synthesis, compounds 3–9 and 21 were synthesized starting
from the unprotected monosaccharides as shown in the support-
ing information.
General on-chip copper(I)-catalyzed alkyne-azide cycloaddi-
tion (CuAAC)
CuSO4 (530 mg, 3.36 mmol, 2.00 equiv) and sodium ascorbate
(998 mg, 5.04 mmol, 3.00 equiv) were added to a mixture of 100 mL
DMSO and 100 mL water in a vial. The vial was shaken for 5 min
and, afterwards, the precipitate was centrifuged and the remaining
solution was passed through a syringe filter (0.2 mm, polypropy-
lene). The sugar azide (1.68 mmol, 1.00 equiv) was dissolved in this
solution and then applied on the acceptor surface (c =
8.4 mmol mL1). For the incubation, we used a 16-well format incu-
bation chamber (PEPperPRINT GmbH, Heidelberg/Baden-Wrttem-
berg, Germany). The prepared solution (200 mL) was poured in one
of the wells and then shaken overnight in the dark. The slide was
washed with water (1  30 min) in a petri dish on a shaker and
dried in a jet of air.
Concanavalin A (ConA) binding assay
Before starting the lectin incubation, the acceptor slide was first in-
cubated with a blocking buffer for fluorescence scanning (Rock-
land, USA, MB-070). For the blocking step, we used a 16-well
format incubation chamber (PEPperPRINT GmbH, Heidelberg/
Baden-Wrttemberg, Germany) and for each well 250 mL of the
blocking buffer were applied. The blocking step was done on a
shaker for 30 min. After the blocking step, the incubation with the
fluorescently labeled ConA lectin (Biotium, Inc. , USA, CF633
ConA) was accomplished. Therefore, the lectin was dissolved in a
HEPES-buffer (50 mm HEPES, 100 mm NaCl, 1 mm CaCl2, 1 mm
MnCl2, 10 % blocking buffer, 0.05 % Tween-20, pH 7.5) at a concen-
tration of 100 mg mL1. For one well, 200 mL of this solution were
applied. The incubation took place for 1 h on a shaker, protected
from light. The slide was washed in the wells of the incubation
chamber with PBS-T (3  300 mL for 5 min) and then the whole
glass slide was dipped into a TRIS buffer (1 mm TRIS, pH 7.4), to
remove salt residues. The slide was dried in a jet of air and fluores-
cence scanning was used to detect the lectin binding.
Langerin binding assay
The acceptor slide was pre-swelled in PBS-T for 15 min on a shaker
in a petri dish. Before starting the lectin incubation, the acceptor
slide was first incubated with a blocking buffer for fluorescence
scanning (Rockland, Limerick/Pennsylvania, USA; blocking buffer
for fluorescent western blotting MB-070). For the blocking step, we
used a 16-well format incubation chamber (PEPperPRINT GmbH,
Heidelberg/Baden-Wrttemberg, Germany) and for each well
250 mL of the blocking buffer were applied. The blocking step was
done on a shaker for 30 min. After the blocking step, the incuba-
tion with the FITC-labeled human langerin ECD (recombinantly ex-
pressed as described previously[32]) was accomplished. Therefore,
the lectin was dissolved in a HEPES-buffer (50 mm HEPES, 100 mm
NaCl, 10 mm CaCl2, 1 mm MnCl2, 10 % blocking buffer, 0.05 %
Tween-20, pH 7.5) at a concentration of 63 mg mL1. For one well,
200 mL of this solution were applied. The incubation took place for
1 h on a shaker protected from light. The slide was washed in the
wells of the incubation chamber with PBS-T (3  200 mL for 5 min)
and then the whole glass slide was dipped into a TRIS buffer
(1 mm TRIS, pH 7.4), to remove salt residues. The slide was dried in
a jet of air and fluorescence scanning was used to detect the lectin
binding.
Fluorescence scan
The fluorescence scan of the CF633 ConA labeled neo-glycopepti-
des and the TAMRA labeled peptides were done on the high reso-
lution microarray scanner GenePix 4000B (Molecular Devices, Sun-
nyvale/California, USA), using an excitation wavelength of 635 nm
or 532 nm at 5 mm resolution, while the fluorescence scan of the
FITC-langerin labeled neo-glycopeptides was done on the high res-
olution microarray scanner GenePix 4300A (Molecular Devices, Sun-
nyvale/California, USA) using an excitation wavelength of 488 nm
at 5 mm resolution. For the analysis of the fluorescence images, we
used the analysis software GenePix Pro 6.0 (Molecular Devices,
Sunnyvale/California, USA). For the spots a circular shape was de-
fined.
Synthesis and analysis of neo-glycopeptides (consisting of
propargylglycine and glycine) regarding multivalency ef-
fects
The peptide tetramers (Figure 2), consisting of propargylglycine
and glycine, were synthesized according to the general on-chip
synthesis of peptides using cLIFT. Therefore, two donor slides were
manufactured, one embedding Fmoc-Pra-OPfp 1 and the other
one Fmoc-Gly-OPfp 2. The sugar azides 3–10, and 21 were then
clicked to the alkyne side chains, following the general on-chip
copper(I)-catalyzed alkyne–azide cycloaddition (CuAAC). For each
of the sugar azides, the reaction was performed in a separate
cavity of a 16-well format incubation chamber on the microarray.
Each cavity contains the peptide tetramer pattern shown in
Figure 2 as three replicas, yielding a total of twelve neo-glycopep-
tide replicas for each combination of a single sugar azide and one
peptide tetramer (three sets of quadruplicates). To detect multiva-
lency effects, the neo-glycopeptides resulting from the mannose
azides 3–6, glucoses 7 and 8 (and galactose 21 as a negative con-
trol) were incubated with fluorescently labeled ConA, using the
above described ConA binding assay (16-well format incubation
chamber) and the ones synthesized with the sugar azides 9 and 10
(and glucose 7 as a negative control) were incubated with fluores-
cently labeled langerin following the above described langerin
binding assay. Consequently, for each neo-glycopeptide, twelve
separate spots were generated on the microarray slide. After fluo-
rescence scanning, the median of the fluorescence intensity was
determined for each spot, using the microarray analysis software
GenePix Pro 6.0. For each set of twelve medians, the mean value
was calculated, where spot values that deviate more than 40 %
from the mean were omitted from the calculation (very few values
were omitted). In case of the langerin binding, the GGGG se-
quence, where no sugar unit is present on the peptide, was used
as the background signal and was subtracted from all other values.
KD,surf determination experiments
The KD,surf values were calculated for the binding of the CF633
ConA lectin to the neo-glycopeptides (tetramers), containing the
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a-mannopyranosyl residue 6. The peptide tetramers (Figure 2) con-
sisting of propargylglycine and glycine were synthesized according
to the general on-chip synthesis of peptides using cLIFT. Therefore,
two donor slides were manufactured, one embedding Fmoc-Pra-
OPfp 1 and the other one Fmoc-Gly-OPfp 2. The mannose azide 6
was then clicked to the alkyne side chains, following the general
on-chip copper(I)-catalyzed alkyne–azide cycloaddition (CuAAC).
The concanavalin A (ConA) binding assay was then performed
using different concentrations of the lectin (45 nm, 90 nm, 180 nm,
360 nm, 720 nm, 1440 nm, 2880 nm, and 5760 nm). The CuAAC as
well as the binding assay were done in a 16-well format incubation
chamber. For each peptide and each concentration, twelve sepa-
rated spots were generated on the microarray slide. After fluores-
cence scanning, the median of the fluorescence intensity was de-
termined for each spot, using the microarray analysis software
GenePix Pro 6.0. For each set of twelve medians, the mean value
was then calculated, where spot values that deviate more than
40 % from the mean were omitted from the calculation (very few
values were omitted, only for high ConA concentrations, where
ConA precipitated). The results were plotted against the different
peptide sequences on the microarray slide for each ConA concen-
tration. The KD,surf values were determined by plotting the means
for each peptide sequence against the concentration on a logarith-
mic scale. Then a nonlinear curve (Category: Growth/Sigmoidal ;
function: DoseResp; iteration algorithm: Levenberg (except BGBB,
using Orthogonal Distance Regression (Pro), showing higher stan-
dard deviation)) was fitted and the KD,surf values were calculated
using the software Origin 2019 (OriginLab, Northhampton/Massa-
chusetts, USA).
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On-Chip Neo-Glycopeptide Synthesis
for Multivalent Glycan Presentation
Interactions of proteins with glycans
rely on multivalency, where multiple ad-
jacent binding events are involved. To
study this glycan density-dependent
binding, a facile technique to synthesize
peptide-based multivalent carbohydrate
scaffolds in parallel, directly on-chip, in
the microarray format, was developed.
This allows to rapidly generate arrays of
multivalent glycan structures, without
the need for individual multistep syn-
theses per compound.
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